The Latest Breaking News from Jazz

An otherwise competitive rivalry turned historically lopsided for one game.

The Jazz's new purple and white jerseys should have never gone away.

The biotech industry's prospects look promising due to the use of advanced technologies like AI and VR for research, the growing popularity of tailored treatments and biotech devices, a rise in chronic diseases, and increased R&D spending. Therefore, investors could consider buying biotech stocks Innoviva (INVA), Halozyme Therapeutics (HALO), Jazz…

Would the Suns actually target Bronny James in the first round?

Could Chicago Bulls forward Patrick Williams sign an offer sheet with the Utah Jazz in free agency?

The use of advanced technologies, growing demand for personalized medicines, and rising investments in R&D are boosting the biotech industry’s prospects. Given this backdrop, investors could consider buying quality biotech stocks: Amgen (AMGN), Jazz Pharmaceuticals (JAZZ), and ANI Pharmaceuticals (ANIP). Read on.

Will the Jazz force the Lakers to trade up for Bronny?

Rudy Gobert has finally found a place where he's appreciated.

The Utah star's stock has exploded since 2022.

Bradley will join the Utah Jazz front office helmed by Jazz team president Danny Ainge, who drafted Bradley for the Celtics.

The biotechnology industry is expected to grow rapidly due to rising demand for personalized medicines, increased R&D spending, and the adoption of AI in the biopharma market. Hence, quality biotech stocks Incyte (INCY), Jazz Pharmaceuticals (JAZZ), and Exelixis (EXEL) could be poised for breakthroughs this month. Read more….